Newsroom

MÜNCHEN & MIAMI--(BUSINESS WIRE)--QAD | Redzone, das Unternehmen hinter der Nummer eins unter den Fertigungsplattformen weltweit, hat eine strategische Partnerschaft mit PwC Belgien bekannt gegeben, die darauf abzielt, Lean Manufacturing, operative Exzellenz und die digitale Transformation der Belegschaft in Industrieunternehmen in Belgien und ganz Europa voranzutreiben. Durch die Kombination von ChampionAI und der führenden Connected Workforce-Lösung von QAD | Redzone mit der umfassenden Ferti...

MUNICH et MIAMI--(BUSINESS WIRE)--QAD | Redzone, l’entreprise à l’origine de la première plateforme mondiale destinée aux fabricants, a annoncé un partenariat stratégique avec PwC Belgique visant à promouvoir la production allégée, l’excellence opérationnelle et la transformation numérique de la main-d’œuvre au sein des entreprises industrielles en Belgique et dans toute l’Europe. En associant ChampionAI et la solution de pointe Connected Workforce de QAD | Redzone à l’expertise approfondie de...

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to three class of notes from Databank Issuer, LLC and Databank Co-Issuer, LLC Series 2026-2, Series 2026-3, and Series 2026-4 (together, Series 2026-2/3/4), a colocation data center ABS transaction. The transaction represents the sixth ABS issuance issued by DataBank Issuer, LLC and DataBank Co-Issuer, LLC. All series share in the same collateral pool, which will be increased with the additional collateral on the closing date of DataBa...

MÜNCHEN & MIAMI--(BUSINESS WIRE)--QAD | Redzone, het bedrijf achter ’s werelds topplatform voor fabrikanten, kondigde een strategisch partnerschap aan met PwC Belgium bedoeld om lean productie, operationele uitmuntendheid en digitale transformatie van personeel te bevorderen voor industriële organisaties in België en heel Europa. Door ChampionAI en de toonaangevende Connected Workforce Solution van QAD | Redzone te combineren met PwC’s grondige productie-expertise en capaciteiten op gebied van...

NEW YORK--(BUSINESS WIRE)--Subversive ETFs today launched the Subversive S&P 500 Redacted ETF (CBOE: XXSP) and the Subversive Growth 100 Redacted ETF (CBOE: XXQQ), two actively managed funds that deliver broad exposure to the S&P 500 and Nasdaq 100, respectively, while excluding equity securities of companies founded, controlled or led by Elon Musk. Musk's companies have grown large enough that most broad market investors already carry meaningful exposure to him personally, whether they...

SINGAPORE--(BUSINESS WIRE)--TechCreate Group Ltd. (OTCMKTS: TCGLF) (“TechCreate” or the “Company”), a technology consultancy and advanced software solutions provider specializing in payment solutions, cybersecurity, and digital services, announced its financial and operational results for the six months ended June 30, 2026. Recent Operational Highlights Notified by NYSE American that the Committee for Review will consider the Company’s request for review of the Panel’s decision on October 22, 2...

PALO ALTO, Calif.--(BUSINESS WIRE)--Nectar, the agentic growth operating system connecting businesses to consumers, today launched Nectar MCP, which connects a brand's Nectar data to ChatGPT, Claude, Gemini and Copilot. It is built on the Model Context Protocol, the open standard AI assistants use to connect to outside data. AI assistants have become where a lot of marketing work happens. Teams have connected them to their sales numbers and their plans, but the assistants still can't see the cu...

REDWOOD CITY, Kalifornien--(BUSINESS WIRE)--Helm.ai, das auf Fundament-Modellen basierende Softwareunternehmen für physikalische KI, gab heute bekannt, dass es innerhalb eines Zeitraums von 12 Monaten kommerzielle Verträge im Wert von 70 Millionen US-Dollar abgeschlossen hat, die sich auf globale Automobilhersteller, Tier-1-Zulieferer und Unternehmen der industriellen Automatisierung erstrecken. Das Unternehmen ist auf dem Weg zur Erreichung der Gewinnschwelle, da es serienreife Automobilprogra...

ANN ARBOR, Mich.--(BUSINESS WIRE)--Sling Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye disease (TED), today announced the presentation of efficacy, safety and new durability results from its Phase 2b/3 LIDS trial of linsitinib in adults with moderate to severe active TED. The data were highlighted in an oral presentation and in a poster session at the American Society of Ophthalmic Plastic and...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversib...